Inventor · disambiguated record
Gerhard Siemeister
Also filed as: SIEMEISTER GERHARD
73 granted patents·66 pending applications·446 citations·filing 2000–2023
98Inventor score
Top patents by PatentIndex Score
139 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0294US7288547B2CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Oct 30, 2007·54 cites·24 claims
- 0393US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 0493US7129254B2Effector conjugates, process for their production and their pharmaceutical useSCHERING AG·Filed 2003·Granted Oct 31, 2006·51 cites·15 claims
- 0592US7312225B2Macrocyclic pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2003·Granted Dec 25, 2007·73 cites·9 claims
- 0692US7235561B2Compound and a composition including such a compoundSCHERING AG·Filed 2002·Granted Jun 26, 2007·58 cites·58 claims
- 0789US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 0889US7598260B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 6, 2009·13 cites·79 claims
- 0986US7511059B2Thiazolidinones, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Mar 31, 2009·14 cites·15 claims
- 1085US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 1185US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
- 1284US7338958B2Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agentsSCHERING AG·Filed 2004·Granted Mar 4, 2008·19 cites·13 claims
- 1383US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 1483US7943629B2Sulphimides as protein kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2007·Granted May 17, 2011·10 cites·24 claims
- 1583US7335775B2Effector conjugates, process for their production and their pharmaceutical useSCHERING AG·Filed 2006·Granted Feb 26, 2008·5 cites·7 claims
- 1682US9388140B2Substituted benzimidazolesKLAR ULRICH·Filed 2012·Granted Jul 12, 2016·3 cites·18 claims
- 1782US7291624B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Nov 6, 2007·16 cites·90 claims
- 1881US11976334B2Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative diseaseBAYER AG·Filed 2021·Granted May 7, 2024·1 cites·6 claims
- 1981US9340528B2Substituted aminoquinoxalines as tyrosine threonine kinase inhibitorsBADER BENJAMIN·Filed 2010·Granted May 17, 2016·12 cites·6 claims
- 2081US8735412B2Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicineLücking Ulrich·Filed 2009·Granted May 27, 2014·6 cites·19 claims
- 2180US11712440B2Predictive markers for ATR kinase inhibitorsBAYER AG·Filed 2018·Granted Aug 1, 2023·1 cites·3 claims
- 2280US9670202B2Substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Jun 6, 2017·2 cites·16 claims
- 2379US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 2478US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 2578US10214542B2Modified macrocyclic compoundsBayer Pharma AG·Filed 2016·Granted Feb 26, 2019·2 cites·27 claims
- 2678US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 2778US8802686B2Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicineLücking Ulrich·Filed 2009·Granted Aug 12, 2014·4 cites·12 claims
- 2877US10717749B2Macrocyclic sulfondiimine compoundsBayer Pharma AG·Filed 2016·Granted Jul 21, 2020·2 cites·17 claims
- 2977US10428063B24H-pyrrolo[3,2-C]pyridin-4-one derivativesBayer Pharma AG·Filed 2016·Granted Oct 1, 2019·3 cites·15 claims
- 3077US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 3177US7456191B2N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agentsSCHERING AG·Filed 2006·Granted Nov 25, 2008·3 cites·27 claims
- 3275US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 3375US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 3475US9255100B2Substituted imidazopyridazinesKLAR ULRICH·Filed 2011·Granted Feb 9, 2016·3 cites·14 claims
- 3574US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 3673US9963464B2Macrocyclic compoundsBayer Pharma AG·Filed 2015·Granted May 8, 2018·2 cites·29 claims
- 3773US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 3873US8993630B2Substituted sulphonamido phenoxybenzamidesHARTUNG INGO·Filed 2009·Granted Mar 31, 2015·2 cites·11 claims
- 3970US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 4069US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 4167US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 4266US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 4366US9790189B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine groupBayer Pharma AG·Filed 2015·Granted Oct 17, 2017·1 cites·26 claims
- 4466US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 4565US9663510B2Substituted triazolopyridines and their use as TTK inhibitorsBAYER IP GMBH·Filed 2012·Granted May 30, 2017·1 cites·27 claims
- 4665US9284317B2Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Mar 15, 2016·1 cites·10 claims
- 4765US9212184B26-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Dec 15, 2015·1 cites·10 claims
- 4864US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 4963US8551980B2Substituted triazolopyridinesSCHULZE VOLKER·Filed 2010·Granted Oct 8, 2013·1 cites·13 claims
- 5062US8507510B2Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agentsLUECKING ULRICH·Filed 2004·Granted Aug 13, 2013·3 cites·20 claims
Showing the top 50 of 139 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gerhard Siemeister files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →